Department of Cardiology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2020-2027. doi: 10.26355/eurrev_202002_20380.
To explore the effect of the micro ribonucleic acid (miR)-223 on the thrombophlebitis rats by regulating the Toll-like receptor (TLR) signaling pathway.
The rat model of thrombophlebitis was established, and miR-223 was silenced or overexpressed through lentiviral transfection. The rats were divided into miR-223 inhibitors group (Inhibitors group), miR-223 mimics group (Mimics group), and normal group (Control group). The transfection efficiency of miR-223 in venous tissues was detected via Reverse Transcription-Polymerase Chain Reaction (RT-PCR), the hemorheological indexes plasma viscosity (PV) and hematocrit (HCT) were observed, and the content of the serum inflammatory factors interleukin-6 (IL-6) and tumor necrosis factor-β (TNF-β) were detected via enzyme-linked immunosorbent assay (ELISA). Moreover, the fibrinolytic indexes plasminogen activator inhibitor (PAI) and the tissue-type plasminogen activator (t-PA) were detected, the morphological changes in the venous tissues were observed via hematoxylin-eosin (HE) staining, and the gene and protein expressions of the TLR signaling pathway were detected via RT-PCR and Western blotting.
The expression of miR-223 was significantly increased in the Mimics group (p<0.05) and significantly decreased in the Inhibitors group (p<0.05). The high-shear and low-shear whole blood viscosity and HCT in the Inhibitors group were significantly higher than those in the Mimics group (p<0.05). The levels of serum IL-6, IL-1β, and TNF-β in the Inhibitors group were remarkably higher than those in the Mimics group (p<0.05). The Inhibitors group had a remarkably lower level of t-PA (p<0.05) and a remarkably higher level of PAI than the Mimics group (p<0.05). Besides, the inferior vena cava wall shed and disappeared due to complete necrosis in the Inhibitors group. In the Mimics group, the vascular lumen was slightly expanded, and the vascular wall had intact contour. It was found in the gene detection that the mRNA levels of TLR2, myeloid differential protein-88 (MyD88) and c-Jun N-terminal kinase (JNK) were evidently increased in the Inhibitors group, and the significant increases in the protein levels of TLR2 and MyD88 were also observed in the protein detection.
The overexpression of miR-223 can inhibit the TLR signaling pathway, thereby promoting the recovery of thrombophlebitis rats.
探讨微小核糖核酸(miR)-223 通过调节 Toll 样受体(TLR)信号通路对血栓性静脉炎大鼠的影响。
建立血栓性静脉炎大鼠模型,通过慢病毒转染沉默或过表达 miR-223。将大鼠分为 miR-223 抑制剂组(抑制剂组)、miR-223 模拟物组(模拟物组)和正常组(对照组)。采用逆转录-聚合酶链反应(RT-PCR)检测静脉组织中 miR-223 的转染效率,观察血液流变学指标血浆黏度(PV)和血细胞比容(HCT),采用酶联免疫吸附试验(ELISA)检测血清炎症因子白细胞介素-6(IL-6)和肿瘤坏死因子-β(TNF-β)的含量。此外,检测纤溶指标纤溶酶原激活物抑制剂(PAI)和组织型纤溶酶原激活物(t-PA),采用苏木精-伊红(HE)染色观察静脉组织形态学变化,采用 RT-PCR 和 Western blot 检测 TLR 信号通路的基因和蛋白表达。
模拟物组 miR-223 的表达明显升高(p<0.05),抑制剂组明显降低(p<0.05)。抑制剂组高剪切和低剪切全血黏度和 HCT 明显高于模拟物组(p<0.05)。抑制剂组血清 IL-6、IL-1β 和 TNF-β 水平明显高于模拟物组(p<0.05)。抑制剂组 t-PA 水平明显低于模拟物组(p<0.05),PAI 水平明显高于模拟物组(p<0.05)。此外,抑制剂组下腔静脉壁完全坏死脱落消失。在模拟物组中,血管腔略有扩张,血管壁轮廓完整。基因检测发现,抑制剂组 TLR2、髓样分化蛋白-88(MyD88)和 c-Jun N 端激酶(JNK)的 mRNA 水平明显升高,蛋白检测也发现 TLR2 和 MyD88 的蛋白水平明显升高。
miR-223 的过表达可抑制 TLR 信号通路,从而促进血栓性静脉炎大鼠的恢复。